Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease

被引:301
作者
Yates, Clara M. [1 ]
Calder, Philip C. [2 ]
Rainger, G. Ed [1 ]
机构
[1] Univ Birmingham, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO16 6YD, Hants, England
关键词
Omega-3 polyunsaturated fatty acid; Eicosapentaenoic acid; Docosahexaenoic acid; Inflammation; Eicosanoid; Resolvin; FISH-OIL SUPPLEMENTATION; TUMOR-NECROSIS-FACTOR; RANDOMIZED CONTROLLED-TRIAL; PROLIFERATOR-ACTIVATED RECEPTORS; CYTOKINE-INDUCED EXPRESSION; EUROPEAN PROSPECTIVE COHORT; PLACEBO-CONTROLLED TRIAL; ALPHA-LINOLENIC ACID; NF-KAPPA-B; DOCOSAHEXAENOIC ACID;
D O I
10.1016/j.pharmthera.2013.10.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Omega-3 (n-3) polyunsaturated fatty acids (n-3 PUFAs) have well documented anti-inflammatory properties, and consequently therapeutic potential in chronic inflammatory diseases. Here we discuss the effects of n-3 PUFAs on various inflammatory pathways and how this leads to alterations in the function of inflammatory cells, most importantly endothelial cells and leukocytes. Strong evidence indicates n-3 PUFAs are beneficial as a dietary supplement in certain diseases such as rheumatoid arthritis; however for other conditions such as asthma, the data are less robust. A clearer understanding of the pharmacology of n-3 PUFAs will help to establish targets to modulate chronic inflammatory diseases. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:272 / 282
页数:11
相关论文
共 50 条
  • [21] Omega-3 polyunsaturated fatty acids and mitochondria, back to the future
    de Oliveira, Marcos Roberto
    Nabavi, Seyed Fazel
    Nabavi, Seyed Mohammad
    Jardim, Fernanda Rafaela
    [J]. TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2017, 67 : 76 - 92
  • [22] Omega-3 polyunsaturated fatty acids for major depressive disorder
    Su, Kuan-Pin
    Wang, Sheng-Min
    Pae, Chi-Un
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (12) : 1519 - 1534
  • [23] Omega-3 polyunsaturated fatty acids and chronic obstructive pulmonary disease
    Wood, Lisa G.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2015, 18 (02) : 128 - 132
  • [24] Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders
    Chitre, Neha M.
    Moniri, Nader H.
    Murnane, Kevin S.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019, 18 (10) : 735 - 749
  • [25] Omega-3 polyunsaturated fatty acids attenuate inflammatory activation and alter differentiation in human adipocytes
    Ferguson, Jane F.
    Roberts-Lee, Kailey
    Borcea, Cristina
    Smith, Holly M.
    Midgette, Yasmeen
    Shah, Rachana
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2019, 64 : 45 - 49
  • [26] Fortification of Foods with Omega-3 Polyunsaturated Fatty Acids
    Ganesan, Balasubramanian
    Brothersen, Carl
    McMahon, Donald J.
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2014, 54 (01) : 98 - 114
  • [27] Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
    Ueno, Yuji
    Miyamoto, Nobukazu
    Yamashiro, Kazuo
    Tanaka, Ryota
    Hattori, Nobutaka
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [28] Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
    Jump, Donald B.
    Lytle, Kelli A.
    Depner, Christopher M.
    Tripathy, Sasmita
    [J]. PHARMACOLOGY & THERAPEUTICS, 2018, 181 : 108 - 125
  • [29] Omega-3 fatty acids and cardiovascular disease
    von Schacky, C
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (02) : 131 - 136
  • [30] Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases
    Jerab, Donia
    Blangero, Ferdinand
    da Costa, Paulo Cesar Trindade
    Alves, Jose Luiz de Brito
    Kefi, Rym
    Jamoussi, Henda
    Morio, Beatrice
    Eljaafari, Assia
    [J]. NUTRIENTS, 2025, 17 (07)